166 related articles for article (PubMed ID: 38708507)
1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract][Full Text] [Related]
2. CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor.
Xiang B; Chen ML; Gao ZQ; Mi T; Shi QL; Dong JJ; Tian XM; Liu F; Wei GH
BMC Med Genomics; 2023 Aug; 16(1):189. PubMed ID: 37592341
[TBL] [Abstract][Full Text] [Related]
3. Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with Wilms tumour.
Tian XM; Xiang B; Jin LM; Mi T; Wang JK; Zhanghuang C; Zhang ZX; Chen ML; Shi QL; Liu F; Lin T; Wei GH
Front Immunol; 2022; 13():920666. PubMed ID: 36172369
[TBL] [Abstract][Full Text] [Related]
4. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
Li Y; Wu D; Wei C; Yang X; Zhou S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
[TBL] [Abstract][Full Text] [Related]
5. Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis.
He Y; Cui X; Lin Y; Wang Y; Wu D; Fang Y
Biomed Res Int; 2021; 2021():8826286. PubMed ID: 33628817
[TBL] [Abstract][Full Text] [Related]
6. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
7. The Regulatory Network and Role of the circRNA-miRNA-mRNA ceRNA Network in the Progression and the Immune Response of Wilms Tumor Based on RNA-Seq.
Tian XM; Xiang B; Zhang ZX; Li YP; Shi QL; Li MJ; Li Q; Yu YH; Lu P; Liu F; Liu X; Lin T; He DW; Wei GH
Front Genet; 2022; 13():849941. PubMed ID: 35559038
[TBL] [Abstract][Full Text] [Related]
8. Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor.
Lin XD; Wu YP; Chen SH; Sun XL; Ke ZB; Chen DN; Li XD; Lin YZ; Wei Y; Zheng QS; Xu N; Xue XY
Mol Genet Genomic Med; 2020 Jan; 8(1):e1032. PubMed ID: 31701684
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
[TBL] [Abstract][Full Text] [Related]
10. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
[TBL] [Abstract][Full Text] [Related]
11. RNA-Sequencing, Connectivity Mapping, and Molecular Docking to Investigate Ligand-Protein Binding for Potential Drug Candidates for the Treatment of Wilms Tumor.
Luo JY; Yan SB; Chen G; Chen P; Liang SW; Xu QQ; Gu JH; Huang ZG; Qin LT; Lu HP; Mo WJ; Luo YG; Chen JB
Med Sci Monit; 2020 Mar; 26():e920725. PubMed ID: 32214060
[TBL] [Abstract][Full Text] [Related]
12. Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
Wang X; Song P; Huang C; Yuan N; Zhao X; Xu C
Mol Med Rep; 2019 Mar; 19(3):2041-2050. PubMed ID: 30664180
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
Zheng H; Li BH; Liu C; Jia L; Liu FT
Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
[TBL] [Abstract][Full Text] [Related]
14. A novel model incorporating chromatin regulatory factors for risk stratification, prognosis prediction, and characterization of the microenvironment in Wilms tumor.
Zhao X; Chu X; Song L; Tang W
J Gene Med; 2024 Jan; 26(1):e3574. PubMed ID: 37578081
[TBL] [Abstract][Full Text] [Related]
15. Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.
Xie J; Chen K; Han H; Dong Q; Wang W
Curr Res Transl Med; 2022 Sep; 70(4):103347. PubMed ID: 35483237
[TBL] [Abstract][Full Text] [Related]
16. Review of prognostic and predictive aspects of mutated TP53 in Wilms' tumor biology with morphological report and molecular analysis of 37-year-old man's nephroblastoma.
Wincewicz A; Kowalik A; Zięba S; Kopczyński J; Góźdź S; Sulkowski S
Pol J Pathol; 2016; 67(4):307-312. PubMed ID: 28547957
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.
Maschietto M; Williams RD; Chagtai T; Popov SD; Sebire NJ; Vujanic G; Perlman E; Anderson JR; Grundy P; Dome JS; Pritchard-Jones K
PLoS One; 2014; 9(10):e109924. PubMed ID: 25313908
[TBL] [Abstract][Full Text] [Related]
18. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
[TBL] [Abstract][Full Text] [Related]
20. Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor.
Liu L; Song Z; Gao XD; Chen X; Wu XB; Wang M; Hong YD
BMC Cancer; 2021 Mar; 21(1):316. PubMed ID: 33765954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
